Cincinnati Edition: Cardiologist develops COVID app to reach African-American communities
UC researcher says technology with better education can empower individuals during pandemic
A University of Cincinnati cardiologist wants to empower communities that have taken a big hit during the COVID-19 pandemic. And he thinks a smartphone app could help.
Donald Lynch, MD, assistant professor of cardiovascular health and disease in the UC College of Medicine, is partnering with researchers in Missouri and Georgia to create an app that delivers COVID-19 information tailored to Black communities.
He spoke with Cincinnati Edition about his work in this area.
"What we know across the country is that COVID has disproportionately affected the African American community and it is unmasking underlying disease," explains Lynch, also a UC Health physician.
He envisions the app providing information on COVID-19 testing sites, self-screening, and providing resources on testing, general health information, and how to access a health care center if necessary.
Listen to Dr. Lynch’s interview with Cincinnati Edition.
Learn more about his smartphone app.
Featured image of smartphone is courtesy of Unsplash.
Impact Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.
UC Board of Trustees approves $12 million for building design phase for new welcome gateway
March 13, 2026
The UC Board of Trustees approved $12 million at its Feb. 24 meeting for the design phase of a new Welcome Gateway Building for Uptown campus.